Replimune Group, Inc. - COMMON STOCK (REPL)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
78.4M
Number of holders
106
Total 13F shares, excl. options
34.7M
Shares change
+342K
Total reported value, excl. options
$1.06B
Value change
+$1.01M
Number of buys
56
Number of sells
-51
Price
$30.51

Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q1 2021

127 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q1 2021.
Replimune Group, Inc. - COMMON STOCK (REPL) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34.7M shares of 78.4M outstanding shares and own 44.24% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.01M shares), Redmile Group, LLC (4.12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.08M shares), BlackRock Inc. (2.22M shares), STATE STREET CORP (1.88M shares), VANGUARD GROUP INC (1.54M shares), Ensign Peak Advisors, Inc (1.4M shares), FMR LLC (1.36M shares), Corriente Advisors, LLC (1.08M shares), and VICTORY CAPITAL MANAGEMENT INC (1.07M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.